Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;128(10):1567-1575.
doi: 10.1007/s00702-021-02355-7. Epub 2021 May 30.

Insights into Lewy body disease from rare neurometabolic disorders

Affiliations
Review

Insights into Lewy body disease from rare neurometabolic disorders

Daniel Erskine et al. J Neural Transm (Vienna). 2021 Oct.

Abstract

Professor Kurt Jellinger is well known for his seminal work on the neuropathology of age-associated neurodegenerative disorders, particularly Lewy body diseases. However, it is less well known that he also contributed important insights into the neuropathological features of several paediatric neurometabolic diseases, including Alpers-Huttenlocher syndrome, a syndrome of mitochondrial disease caused by POLG mutations, and infantile neuroaxonal dystrophy, a phenotype resulting from PLA2G6 mutations. Despite these rare diseases occurring in early life, they share many important pathological overlaps with age-associated Lewy body disease, particularly dysregulation of α-synuclein. In this review, we describe several neurometabolic diseases linked to Lewy body disease mechanisms, and discuss the wider context to pathological overlaps between neurometabolic and Lewy body diseases. In particular, we will focus on how understanding disease mechanisms in neurometabolic disorders with dysregulated α-synuclein may generate insights into predisposing factors for α-synuclein aggregation in idiopathic Lewy body diseases.

Keywords: Alpha-synuclein; Cholesterol; Iron; Lewy body; Mitochondria; Sphingolipids.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflict of interest.

Figures

Fig. 1
Fig. 1
In contrast to control cerebellum, which shows a clear layer of Purkinje cells (arrows) on H&E stain (A.i.), individuals with POLG mutations typically show a loss of Purkinje cells, with some dystrophic remnants of Purkinje cells (arrow), alongside associated Bergmann gliosis (arrowheads; A.ii.). The substantia nigra of a 59 year old male with a POLG mutation shows α-synuclein-immunoreactive Lewy bodies (arrowheads; B.i.), as does the temporal cortex of a 79 year old male with a POLG mutation (arrowheads; B.ii.). Krabbe disease patients show clusters of lipid-filled multi-nucleated globoid cells (arrowheads) and single mononucleated foamy macrophages (arrows) in the medial lemniscus of a 10 month old male (C.i.) and occipital white matter of a 9 month old male (C.ii.). α-Synuclein immunohistochemistry of Krabbe disease cases demonstrates spherical inclusions in frontal cortex of a 10 month old male (D.i.) and the putamen of a 12 month old female (D.ii.). Scale bars = 200 µm (A.i., B.i., B.ii.), 100 µm (A.ii., C.i., C.ii., D.i.), 50 µm (D.ii.)

References

    1. Abdelkarim H, Marshall MS, Scesa G, Smith RA, Rue E, Marshall J, Bongarzone ER, et al. alpha-Synuclein interacts directly but reversibly with psychosine: implications for alpha-synucleinopathies. Sci Rep. 2018;8(1):12462. doi: 10.1038/s41598-018-30808-9. - DOI - PMC - PubMed
    1. Babin PL, Rao SNR, Chacko A, Alvina FB, Panwala A, Panwala L, Fumagalli DC. Infantile neuroaxonal dystrophy: diagnosis and possible treatments. Front Genet. 2018;9:597. doi: 10.3389/fgene.2018.00597. - DOI - PMC - PubMed
    1. Bassil F, Meymand ES, Brown HJ, Xu H, Cox TO, Pattabhiraman S, Lee VM, et al. alpha-Synuclein modulates tau spreading in mouse brains. J Exp Med. 2021 doi: 10.1084/jem.20192193. - DOI - PMC - PubMed
    1. Bencheikh BOA, Senkevich K, Rudakou U, Yu E, Mufti K, Ruskey JA, Gan-Or Z, et al. Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's disease. Neurobiol Aging. 2020;93:143 e141–143 e144. doi: 10.1016/j.neurobiolaging.2020.03.021. - DOI - PMC - PubMed
    1. Bentley SR, Shan J, Todorovic M, Wood SA, Mellick GD. Rare POLG1 CAG variants do not influence Parkinson's disease or polymerase gamma function. Mitochondrion. 2014;15:65–68. doi: 10.1016/j.mito.2014.01.004. - DOI - PubMed

Substances